Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome.
about
The mucosal immune system: master regulator of bidirectional gut-brain communications.Elevations in serum anti-flagellin and anti-LPS Igs are related to growth faltering in young Tanzanian children.Ameliorative effects of atractylodin on intestinal inflammation and co-occurring dysmotility in both constipation and diarrhea prominent ratsSystemic symptoms in irritable bowel syndrome: An investigative study on the role of enterocyte disintegrity, endotoxemia and inflammationBiomarkers as a diagnostic tool for irritable bowel syndrome: where are we?Irritable bowel syndrome: a gut microbiota-related disorder?Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome.From clinical uncertainties to precision medicine: the emerging role of the gut barrier and microbiome in small bowel functional diseases.Gastrointestinal neuromuscular apparatus: An underestimated target of gut microbiota.Supernatants of irritable bowel syndrome mucosal biopsies impair human colonic smooth muscle contractility.Decreased TESK1-mediated cofilin 1 phosphorylation in the jejunum of IBS-D patients may explain increased female predisposition to epithelial dysfunction.Repeated water avoidance stress induces visceral hypersensitivity: Role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor.FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction.Glucagon-like peptide-1 analog, liraglutide, improves visceral sensation and gut permeability in rats.Lipopolysaccharide induces visceral hypersensitivity: role of interleukin-1, interleukin-6, and peripheral corticotropin-releasing factor in rats.Current insights into the innate immune system dysfunction in irritable bowel syndrome.Biomarkers of maternal environmental enteric dysfunction are associated with shorter gestation and reduced length in newborn infants in Uganda
P2860
Q36252032-40AF5E63-33D3-4FE7-B479-99C4C9557D7AQ36937657-8CDFA4B3-FB05-4B9F-A145-EF5A480816EEQ37559541-6435F751-D0DF-4B3D-88B8-DDF5AC022832Q37707660-C642887C-B54F-40B2-B191-A49520705D55Q38765085-840DE33E-49CE-43F4-BAAD-3E762DAD59FDQ39018403-48550EDC-A028-4009-BF0D-D010CACB7F87Q39058964-40C1CC41-1A00-4961-8839-20881B95575CQ39376100-8BE72BA0-D234-4BAD-87EA-EEC387703FD0Q42356646-9FBC77E5-A698-4765-B8AA-A5B0F29EF816Q42498868-D79FD47B-A70C-4EA8-BDA5-AE647CD95E02Q48112942-58C3261E-4959-4EAE-AFAB-E7F81454EF63Q48261094-A09D0127-D246-4190-9599-8B09B0CDB0DFQ50088048-C4FB5193-F260-4A6E-A0A3-9BCD49FD2439Q50178398-83A0DFC2-4237-4DD3-9230-816CABEC9D03Q51372487-5E9517BE-FFD9-45BB-AF06-B9B85836FC33Q52673108-97AE941B-54C0-4705-BC9F-8CB2E3FCB2B1Q56909259-4662A825-EDE8-4025-941F-B600C9B16D9A
P2860
Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Increased serum levels of lipo ...... nant irritable bowel syndrome.
@ast
Increased serum levels of lipo ...... nant irritable bowel syndrome.
@en
type
label
Increased serum levels of lipo ...... nant irritable bowel syndrome.
@ast
Increased serum levels of lipo ...... nant irritable bowel syndrome.
@en
prefLabel
Increased serum levels of lipo ...... nant irritable bowel syndrome.
@ast
Increased serum levels of lipo ...... nant irritable bowel syndrome.
@en
P2093
P2860
P50
P356
P1476
Increased serum levels of lipo ...... nant irritable bowel syndrome.
@en
P2093
G Lindberg
G Mohammadian Kermani
S Abdurahman
P2860
P304
P356
10.1111/NMO.12670
P577
2015-09-21T00:00:00Z